Characteristics | No. (%), n = 45 |
---|---|
Male sex | 38 (84) |
Specialty | |
Cardiology | 7 (16) |
Pulmonology | 20 (44) |
Rheumatology | 17 (38) |
Internal medicine | 1 (2) |
No. years seeing patients with pulmonary arterial hypertension (PAH), median (25%–75%) | 15 (10–25) |
Type of practice (%) | |
Nonteaching hospital | 0 (0) |
Teaching hospital | 44 (98) |
Both | 1 (2) |
No. new SSc-PAH and/or IPAH patients per year, median (25%–75%) | 30 (15–50) |
Location of practice | |
Europe | 8 (18) |
North America | 37 (82) |
History of postsecondary statistical training | 27 (60) |
Use of warfarin in their patients with pulmonary hypertension | 38 (84) |
SSc: systemic sclerosis; IPAH: idiopathic pulmonary arterial hypertension.